Percutaneous Coronary Intervention

Women are more likely to have an in-hospital vs. out-of-hospital STEMI, with women experiencing an average 10‐minute delay from symptom onset to reperfusion compared with men, according to an analysis of registry data.

An ultrathin-strut bioresorbable polymer sirolimus-eluting stent continued to outperform a durable-polymer drug-eluting stent at 5 years, researchers reported at Cardiovascular Research Technologies.

Teleflex Inc. announced that the FDA has granted an expanded indication for its specialty catheters and coronary guidewires for use in PCI for chronic total occlusions.

10-year mortality according to presence of highly calcified lesions in high-risk patients with CAD who had CABG or PCI with DES.

Among postmenopausal women with acute MI, Black women were less likely to receive revascularization, particularly PCI, compared with white women, researchers reported.

CVD is the leading cause of death in women globally, but women are less likely to receive CV procedures than men, and not enough is known about sex differences for those procedures, a panel concluded.

Health status improved for men and women after nonprimary PCI, but researchers observed more limited improvement among women, with worse health status compared with men at 6 weeks and 9 months after PCI.

Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates significantly declining for patients with non-STEMI and remaining stable for patients with STEMI.

In a meta-analysis of seven trials, colchicine was associated with reduced risk for MACE in patients with CAD who underwent PCI.

For Medicare beneficiaries presenting with acute MI, HF or ischemic stroke, admission to a rural hospital was associated with lower procedure rates and greater risk for 30- and 90-day mortality compared with admission to an urban hospital.